Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001423842 | SCV001626430 | likely benign | Ehlers-Danlos syndrome, musculocontractural type 2 | 2025-01-20 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV003169338 | SCV003869999 | uncertain significance | Inborn genetic diseases | 2023-02-28 | criteria provided, single submitter | clinical testing | The c.1381G>A (p.A461T) alteration is located in exon 6 (coding exon 5) of the DSE gene. This alteration results from a G to A substitution at nucleotide position 1381, causing the alanine (A) at amino acid position 461 to be replaced by a threonine (T). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |